Grants and Contributions
About this information
In June 2016, as part of the Open Government Action Plan, the Treasury Board of Canada Secretariat (TBS) committed to increasing the transparency and usefulness of grants and contribution data and subsequently launched the Guidelines on the Reporting of Grants and Contributions Awards, effective April 1, 2018.
The rules and principles governing government grants and contributions are outlined in the Treasury Board Policy on Transfer Payments. Transfer payments are transfers of money, goods, services or assets made from an appropriation to individuals, organizations or other levels of government, without the federal government directly receiving goods or services in return, but which may require the recipient to provide a report or other information subsequent to receiving payment. These expenditures are reported in the Public Accounts of Canada. The major types of transfer payments are grants, contributions and \'other transfer payments\'.
Included in this category, but not to be reported under proactive disclosure of awards, are (1) transfers to other levels of government such as Equalization payments as well as Canada Health and Social Transfer payments. (2) Grants and contributions reallocated or otherwise redistributed by the recipient to third parties; and (3) information that would normally be withheld under the Access to Information Act and the Privacy Act.
$399,089.00
Apr 1, 2020
Individual or sole proprietorship
Operating Grant: COVID-19 - Social dynamics, communication and trust
155046
The specific objectives of the Canadian 2019-nCoVrapid research funding opportunity are to:
• Contribute to the global response to the 2019-nCoV outbreak;
• Enhance local, national and/or international collaborative efforts to mitigate the rapid spread of 2019-nCoV and its potential negative consequences;
• Strengthen the understanding of the impact of 2019-nCoV on individuals and communities; and
• Provide evidence to inform clinical and public health response, and/or decision-making and planning at national and international levels.
$666,667.00
Apr 1, 2020
Individual or sole proprietorship
Operating Grant: COVID-19 - Transmission dynamics/animal host/modeling
154980
The specific objectives of the Canadian 2019-nCoVrapid research funding opportunity are to:
• Contribute to the global response to the 2019-nCoV outbreak;
• Enhance local, national and/or international collaborative efforts to mitigate the rapid spread of 2019-nCoV and its potential negative consequences;
• Strengthen the understanding of the impact of 2019-nCoV on individuals and communities; and
• Provide evidence to inform clinical and public health response, and/or decision-making and planning at national and international levels.
$317,176.00
Apr 1, 2020
Individual or sole proprietorship
Operating Grant: COVID-19 - Public health response and its impact
155049
The specific objectives of the Canadian 2019-nCoVrapid research funding opportunity are to:
• Contribute to the global response to the 2019-nCoV outbreak;
• Enhance local, national and/or international collaborative efforts to mitigate the rapid spread of 2019-nCoV and its potential negative consequences;
• Strengthen the understanding of the impact of 2019-nCoV on individuals and communities; and
• Provide evidence to inform clinical and public health response, and/or decision-making and planning at national and international levels.
$516,980.00
Apr 1, 2020
Individual or sole proprietorship
Operating Grant: COVID-19 - Diagnostics
154989
The specific objectives of the Canadian 2019-nCoVrapid research funding opportunity are to:
• Contribute to the global response to the 2019-nCoV outbreak;
• Enhance local, national and/or international collaborative efforts to mitigate the rapid spread of 2019-nCoV and its potential negative consequences;
• Strengthen the understanding of the impact of 2019-nCoV on individuals and communities; and
• Provide evidence to inform clinical and public health response, and/or decision-making and planning at national and international levels.
$308,183.00
Apr 1, 2020
Individual or sole proprietorship
Operating Grant: COVID-19 - Social dynamics, communication and trust
154995
The specific objectives of the Canadian 2019-nCoVrapid research funding opportunity are to:
• Contribute to the global response to the 2019-nCoV outbreak;
• Enhance local, national and/or international collaborative efforts to mitigate the rapid spread of 2019-nCoV and its potential negative consequences;
• Strengthen the understanding of the impact of 2019-nCoV on individuals and communities; and
• Provide evidence to inform clinical and public health response, and/or decision-making and planning at national and international levels.
$970,702.00
Apr 1, 2020
Individual or sole proprietorship
Operating Grant: COVID-19 - Diagnostics
154972
The specific objectives of the Canadian 2019-nCoVrapid research funding opportunity are to:
• Contribute to the global response to the 2019-nCoV outbreak;
• Enhance local, national and/or international collaborative efforts to mitigate the rapid spread of 2019-nCoV and its potential negative consequences;
• Strengthen the understanding of the impact of 2019-nCoV on individuals and communities; and
• Provide evidence to inform clinical and public health response, and/or decision-making and planning at national and international levels.
$997,683.00
Apr 1, 2020
Individual or sole proprietorship
Operating Grant: COVID-19 Clinical Epidemiology Research Rapid Response
155058
The purpose of this funding opportunity is to develop and deploy a clinical epidemiology research protocol to a number of surveillance network sites in order to enable rapid implementation in the event of an outbreak of COVID-19 in Canada. The proposed research will collect epidemiological, clinical, and laboratory characteristics of the disease outbreak in Canada, with the following objectives:
• Describe the clinical presentation and spectrum of disease in sentinel hospital sites in Canada;
• Describe key epidemiological characteristics such as incubation period, case-fatality rate, and risk factors in Canada;
• Characterize the duration of viral shedding;
• Describe the response to treatment, including standard of care and potentially approved novel therapeutics, if any;
• Understand risk factors associated with different clinical outcomes following infection; and
• Support development of evidence-informed clinical guidance and recommendations.
$248,800.00
Apr 1, 2020
Individual or sole proprietorship
Operating Grant: COVID-19 - Therapeutics
155041
The specific objectives of the Canadian 2019-nCoVrapid research funding opportunity are to:
• Contribute to the global response to the 2019-nCoV outbreak;
• Enhance local, national and/or international collaborative efforts to mitigate the rapid spread of 2019-nCoV and its potential negative consequences;
• Strengthen the understanding of the impact of 2019-nCoV on individuals and communities; and
• Provide evidence to inform clinical and public health response, and/or decision-making and planning at national and international levels.
$600,000.00
Apr 1, 2020
Individual or sole proprietorship
Operating Grant: COVID-19 - Vaccines
155045
The specific objectives of the Canadian 2019-nCoVrapid research funding opportunity are to:
• Contribute to the global response to the 2019-nCoV outbreak;
• Enhance local, national and/or international collaborative efforts to mitigate the rapid spread of 2019-nCoV and its potential negative consequences;
• Strengthen the understanding of the impact of 2019-nCoV on individuals and communities; and
• Provide evidence to inform clinical and public health response, and/or decision-making and planning at national and international levels.
$308,300.00
Apr 1, 2020
Individual or sole proprietorship
Operating Grant: COVID-19 - Public health response and its impact
155050
The specific objectives of the Canadian 2019-nCoVrapid research funding opportunity are to:
• Contribute to the global response to the 2019-nCoV outbreak;
• Enhance local, national and/or international collaborative efforts to mitigate the rapid spread of 2019-nCoV and its potential negative consequences;
• Strengthen the understanding of the impact of 2019-nCoV on individuals and communities; and
• Provide evidence to inform clinical and public health response, and/or decision-making and planning at national and international levels.